We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 02, 2022

Impact of Low vs Negative ER/PR Status on Clinicopathologic Characteristics and Survival Outcomes in HER2-Negative Breast Cancer

NPJ breast cancer


Additional Info

NPJ breast cancer
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer
NPJ Breast Cancer 2022 Jul 11;8(1)80, R Yoder, BF Kimler, JM Staley, K Schwensen, YY Wang, K Finke, A O'Dea, L Nye, M Elia, G Crane, R McKittrick, R Pluenneke, S Madhusudhana, L Beck, A Shrestha, L Corum, M Marsico, SR Stecklein, AK Godwin, QJ Khan, P Sharma

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading